Applied DNA Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch APDN and buy or sell other stocks, ETFs, and their options commission-free!

About APDN

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. 

CEO
Clay D. Shorrock
CEOClay D. Shorrock
Employees
26
Employees26
Headquarters
Stony Brook, New York
HeadquartersStony Brook, New York
Founded
1983
Founded1983
Employees
26
Employees26

APDN Key Statistics

Market cap
27.82M
Market cap27.82M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
64.43K
Average volume64.43K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$48.38
52 Week high$48.38
52 Week low
$0.6053
52 Week low$0.6053

Stock Snapshot

With a market cap of 27.82M, Applied DNA Sciences(APDN) trades at $5.83.

During the trading day, Applied DNA Sciences(APDN) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Applied DNA Sciences(APDN) stock has reached 0, versus its average volume of 64.43K.

The stock's 52-week range extends from a low of $0.61 to a high of $48.38.

The stock's 52-week range extends from a low of $0.61 to a high of $48.38.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.